Arcadia Biosciences, Inc. Annual Income Tax Expense (Benefit) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Arcadia Biosciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2014 to 2023.
  • Arcadia Biosciences, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • Arcadia Biosciences, Inc. annual Income Tax Expense (Benefit) for 2023 was $8K, a 42.9% decline from 2022.
  • Arcadia Biosciences, Inc. annual Income Tax Expense (Benefit) for 2022 was $14K, a 600% increase from 2021.
  • Arcadia Biosciences, Inc. annual Income Tax Expense (Benefit) for 2021 was $2K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $8K -$6K -42.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $14K +$12K +600% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $2K +$126K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$124K -$126K -6300% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $2K -$8K -80% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $10K -$16K -61.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-25
2017 $26K +$1K +4% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $25K -$1K -3.85% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-20
2015 $26K -$237K -90.1% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-08
2014 $263K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.